Echo Therapeutics is developing its non-invasive, wireless, continuous glucose monitoring (CGM) system to be used in the fitness, weight loss and personal lifestyle wearable-health space. The company is also focused on a longer-term application opportunity which exists in the outpatient diabetes and hospital settings. Echo developed its needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose, and enhanced delivery of topical pharmaceuticals. For more information, visit the company’s website at www.echotx.com